{
    "organizations": [],
    "uuid": "06706c1789a318a7fd550583d39d0f0d3c298fcc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-probi-clinical-trial-confirms-immu/brief-probi-clinical-trial-confirms-immune-enhancing-impact-of-probi-defendum-idUSFWN1PW089",
    "ord_in_thread": 0,
    "title": "BRIEF-Probi: Clinical Trial Confirms Immune Enhancing Impact Of Probi Defendum",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 6 (Reuters) - PROBI:\n* LARGEST CLINICAL TRIAL CONFIRMS THE IMMUNE ENHANCING IMPACT OF PROBI DEFENDUM® AND SHEDS NEW LIGHT ON THE MECHANISM\n* ‍RESULTS FROM STUDY SHOW THAT PROBI DEFENDUM® SIGNIFICANTLY DECREASES RECURRENT COMMON COLDS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-06T17:34:00.000+02:00",
    "crawled": "2018-02-07T22:10:46.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "probi",
        "largest",
        "clinical",
        "trial",
        "confirms",
        "immune",
        "enhancing",
        "impact",
        "probi",
        "shed",
        "new",
        "light",
        "mechanism",
        "study",
        "show",
        "probi",
        "significantly",
        "decrease",
        "recurrent",
        "common",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}